Global Tyrosine Kinase JAK Inhibitors Market Report By Type (Tofacitinib, Ruxolitinib, And Baricitinib), Applications (Rheumatoid Arthritis (RA), Polycythemia Vera (PCV), Myelofibrosis (MF), And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Tyrosine Kinase JAK Inhibitors Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11211133

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

As per this study the Global Tyrosine Kinase JAK Inhibitors Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2028 with a CAGR of XX%. By volume, the market was estimated XX KT in 2021 and is expected to reach XX KT by 2028 with a CAGR of XX%.

JAK inhibitors are also known as Janus kinase inhibitors are categorized under those enzymes which play a significant role in the synthesis of blood cells, promote cell growth and immune responses in the human body. There are basically four members in the JAK family which include JAK-1, 2, 3 and Tyrosine Kinase 2 (TYK2). Moreover, these inhibitors act as a therapeutic agent in the treatment of chronic disease like cancer and inflammatory because its prime function is to restrict the formation of lymphocytes.

Market Dynamics

The growth of the tyrosine kinase inhibitors can be attributed to the rising prevalence of cancer and autoimmune disease across the globe coupled with the expanding healthcare sector. Rising adoption of tyrosine kinase inhibitors for the treatment of cancer because of specificity and various benefits over radiotherapy and chemotherapy is further expected to favor market growth. Ongoing development of novel drugs for the treatment of cancer coupled with the rising investment in the healthcare and pharmaceutical industry by respective regulatory bodies is also projected to raise the market value over the forecast timeline.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of tyrosine kinase JAK inhibitors.

Market Segmentation

The broad tyrosine kinase JAK inhibitors market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Type

Tofacitinib
Ruxolitinib
Baricitinib

By Application

Rheumatoid Arthritis (RA)
Polycythemia Vera (PCV)
Myelofibrosis (MF)
Others

Regional Analysis

Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for tyrosine kinase JAK inhibitors in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Global Tyrosine Kinase JAK Inhibitors Market Share by Region (Representative Graph)

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the tyrosine kinase JAK inhibitors market includes AbbVie, Astellas Pharma, Celgene, CTI BioPharma, Eli Lilly, Galapagos, Gilead, Incyte, Novartis, Pfizer, Sanofi, Teva, Vertex, and others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Tyrosine Kinase Jak Inhibitors Market
       2.2. Global Tyrosine Kinase Jak Inhibitors Market Snapshot

3 . TYROSINE KINASE JAK INHIBITORS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Tyrosine Kinase Jak Inhibitors Market
       3.3. Market Restraints of Tyrosine Kinase Jak Inhibitors Market
       3.4. Opportunities of Tyrosine Kinase Jak Inhibitors Market
       3.5. Trends of Tyrosine Kinase Jak Inhibitors Market
       3.6. Porter’s Five Force Analysis of Tyrosine Kinase Jak Inhibitors Market
       3.7. Tyrosine Kinase Jak Inhibitors Market Attractiveness Analysis
          3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Tyrosine Kinase Jak Inhibitors Value Chain Analysis
       4.2. Tyrosine Kinase Jak Inhibitors Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Tyrosine Kinase Jak Inhibitors Raw Material Manufactures List
           4.2.3. Price Trend of Tyrosine Kinase Jak Inhibitors Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . GLOBAL TYROSINE KINASE JAK INHIBITORS MARKET ANALYSIS BY TYPE
       5.1 Overview by Type
       5.2 Global Tyrosine Kinase Jak Inhibitors Market Analysis by Type
       5.3 Market Analysis of Tofacitinib by Regions
       5.4 Market Analysis of Ruxolitinib by Regions
       5.5 Market Analysis of Baricitinib by Regions

6 . GLOBAL TYROSINE KINASE JAK INHIBITORS MARKET ANALYSIS BY APPLICATION
       6.1 Overview by Application
       6.2 Global Tyrosine Kinase Jak Inhibitors Market Analysis by Application
       6.3 Market Analysis of Rheumatoid Arthritis (RA) by Regions
       6.4 Market Analysis of Polycythemia Vera (PCV) by Regions
       6.5 Market Analysis of Myelofibrosis (MF) by Regions
       6.6 Market Analysis of Others by Regions

7 . GLOBAL TYROSINE KINASE JAK INHIBITORS MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Tyrosine Kinase Jak Inhibitors Market Estimate by Market Segment
           7.3.3. North America Tyrosine Kinase Jak Inhibitors Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Tyrosine Kinase Jak Inhibitors Market Estimate by Market Segment
           7.4.3. Europe Tyrosine Kinase Jak Inhibitors Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Tyrosine Kinase Jak Inhibitors Market Estimate by Market Segment
           7.5.3. Asia Pacific Tyrosine Kinase Jak Inhibitors Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Tyrosine Kinase Jak Inhibitors Market Estimate by Market Segment
           7.6.3. Latin America Tyrosine Kinase Jak Inhibitors Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Tyrosine Kinase Jak Inhibitors Market Estimate by Market Segment
           7.7.3. Middle East & Africa Tyrosine Kinase Jak Inhibitors Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa

8 . COMPETITIVE LANDSCAPE OF THE TYROSINE KINASE JAK INHIBITORS COMPANIES
       8.1. Tyrosine Kinase Jak Inhibitors Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments

9 . COMPANY PROFILES OF TYROSINE KINASE JAK INHIBITORS INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. AbbVie
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Astellas Pharma
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Celgene
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. CTI BioPharma
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Eli Lilly
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Galapagos
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Gilead
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Incyte
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Novartis
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. Pfizer
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments
       9.13. Sanofi
           9.13.1. Company Overview
           9.13.2. Financials
           9.13.3. Products
           9.13.4. Recent Developments
       9.14. Teva
           9.14.1. Company Overview
           9.14.2. Financials
           9.14.3. Products
           9.14.4. Recent Developments
       9.15. Vertex
           9.15.1. Company Overview
           9.15.2. Financials
           9.15.3. Products
           9.15.4. Recent Developments
       9.16. Others
           9.16.1. Company Overview
           9.16.2. Financials
           9.16.3. Products
           9.16.4. Recent Developments

10. IMPACT ANALYSIS OF COVID-19 OUTBREAK
10.1. Impact Analysis of Covid-19 Outbreak on the Market
10.1.1. Direct Impact on Production
10.1.2. Supply Chain and Market Disruption
10.1.3. Financial Impact on Firms and Financial Markets
10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
10.3. Pre V/S Post COVID-19 Market
10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
10.5. COVID-19: Micro and Macro Factor Analysis on the Market

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Tyrosine Kinase Jak Inhibitors Report
Market Research Process
Market Research Methodology
Global Tyrosine Kinase Jak Inhibitors Market Size, by Region (2019)
Porters Five Forces Analysis
Market Attractiveness Analysis by Type
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Tyrosine Kinase Jak Inhibitors Market Analysis by Type
Global Tyrosine Kinase Jak Inhibitors Market Analysis in Tofacitinib by Region
Global Tyrosine Kinase Jak Inhibitors Market Analysis in Ruxolitinib by Region
Global Tyrosine Kinase Jak Inhibitors Market Analysis in Baricitinib by Region
Global Tyrosine Kinase Jak Inhibitors Market Analysis by Application
Global Tyrosine Kinase Jak Inhibitors Market Analysis in Rheumatoid Arthritis (RA) by Region
Global Tyrosine Kinase Jak Inhibitors Market Analysis in Polycythemia Vera (PCV) by Region
Global Tyrosine Kinase Jak Inhibitors Market Analysis in Myelofibrosis (MF) by Region
Global Tyrosine Kinase Jak Inhibitors Market Analysis in Others by Region
Global Tyrosine Kinase Jak Inhibitors Market by Volume And Revenue
North America Tyrosine Kinase Jak Inhibitors Market by Volume And Revenue
Europe Tyrosine Kinase Jak Inhibitors Market by Volume And Revenue
Asia Pacific Tyrosine Kinase Jak Inhibitors Market by Volume And Revenue
Latin America Tyrosine Kinase Jak Inhibitors Market by Volume And Revenue
Middle East & Africa Tyrosine Kinase Jak Inhibitors Market by Volume And Revenue
Recent Development in Tyrosine Kinase Jak Inhibitors Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "